documents: FDA-2005-N-0021-0007
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0021-0007 | FDA | FDA-2005-N-0021 | Letter from FDA CDER to Representatives of Symrise Inc. re: Climbazole TEA and Proctor & Gamble | Other | Letter(s) | 2019-08-29T04:00:00Z | 2019 | 8 | 2019-08-29T04:00:00Z | 2020-10-29T12:59:54Z | 0 | 0 | 0900006483ed9393 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref